Respiratory

In unanimous fashion, the FDA AMDAC voted 21 to 0 that nirsevimab has a favorable benefit risk profile for the prevention of RSV lower respiratory tract disease (LRTD) in newborns and infants during their first RSV season.

Nirsevimab’s efficacy against infant hospitalizations due to respiratory syncytial virus was reinforced after a phase 3b clinical trial, demonstrating an 83% reduction in infant hospitalizations.

Hidden triggers and asthma mimickers can complicate this common childhood condition.

How much progress have we made in developing therapies to treat this common childhood respiratory disorder?

New data quantify the exposure to wildfire particulate matter among schoolchildren in California, finding that interventions in a small number of schools may reduce the overall burden of wildfire PM2.5 exposure.

In a recent study, vaccination administered during pregnancy was effective against severe lower respiratory tract illness associated with respiratory syncytial virus (RSV) in infants.

New maternal vaccine options could offer extra protection in upcoming seasons.

In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.

A research letter addresses the challenges of accurately diagnosing asthma, atopic eczema, and allergic rhinitis in children under 5 years old and the use of Read codes and prescription data as diagnostic criteria.

The specific mechanisms involved in associations between air pollution and respiratory illness without viral infection are not understood, especially compared with those of respiratory viruses and asthma exacerbation.

In a recent statement, the American Academy of Pediatrics discussed how patients with respiratory infections can be managed, along with guidance on RSV treatment.

Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discussed the potential threat of a “triple epidemic” of RSV, influenza, and COVID-19, and how pediatricians can identify these viruses in their communities.

Help your patients have a safe and healthy academic year.

For the first time, investigators broke down into narrow age bands morbidity and mortality estimates for respiratory syncytial virus (RSV).

A recent study examined the links between breastfeeding and preterm birth history with hospitalization duration due to LRTIs in infants and toddlers.

The FDA recently announced an e-cigarette prevention campaign aimed at Native American and Alaskan Native youth using prominent social media sites and traditional media like billboards, radio, and TV.

Patience and antimicrobial stewardship are key to treating sinusitis.

A new study examines the relationship between an extended duration of mother-child breastfeeding and protective associations to asthma.

Find out the various ways you can connect and learn through the Leukemia & Lymphoma Society!

Previous investigation has shown that common measurements and tools may not be as accurate in non-White patients as they are in White patients. A new investigation dives into whether pulse oximetry falls into this category.

An investigation examines what demographic factors and less-than-optimal respiratory support in or beyond the neonatal intensive care unit can increase the risk of abnormal lunch function on extremely low gestational age newborns (ELGANs).

An investigation examines whether a treatment of hydrocortisone could lead to a reduction in moderate to severe bronchopulmonary dysplasia and neurodevelopmental outcomes at age 2 years.

What the HCP community can do to change our approach

Thirdhand smoke exposure poses a health threat to children. New research examines the factors that may lead to some children having more exposure than others.

Decreased lung function may be a result of a preterm delivery. Does treatment with long-acting β2 agonists (LABA) plus inhaled corticosteroids perform better than just inhaled corticosteroids to improve lung function in affected children?

Used to treat asthma in adolescents and adults, a clinical trial examines whether it would be effective in treating uncontrolled asthma in younger children.

In spite of the availability of effective treatments, asthma is not always well controlled among teenagers. An investigation examines whether using peers to helm education efforts can lead to improved outcomes.

The jury is out on whether testing or exposure better explains the unseasonable surge of respiratory syncytial virus.

The US Food and Drug Administration has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.

The National Institutes of Health announced the launch of a long-term study into the long ranging outcomes of recovering from COVID-19 in children, adolescents, and young adults.